Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
暂无分享,去创建一个
Y. Pijnenburg | H. J. Schelhaas | M. Verbeek | G. Binetti | B. Küsters | N. Verwey | C. Teunissen | L. Benussi | R. Ghidoni | A. Versleijen | H. B. Kuiperij | Anna Paterlini | J. Raaphorst | M. Beenes | H. Kuiperij
[1] J. Trojanowski,et al. TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies , 2015, Acta neuropathologica communications.
[2] S. Sorbi,et al. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[3] A. Ludolph,et al. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[4] J. Molinuevo,et al. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[5] Chadwick M. Hales,et al. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP , 2013, Neurology.
[6] T. Beach,et al. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies , 2013, Acta Neuropathologica.
[7] D. Mann,et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. , 2012, Brain : a journal of neurology.
[8] G. Binetti,et al. Losing protein in the brain: The case of progranulin , 2012, Brain Research.
[9] L. H. van den Berg,et al. TDP-43 plasma levels are higher in amyotrophic lateral sclerosis , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[10] W. F. Abdo,et al. CSF α-synuclein does not differentiate between parkinsonian disorders , 2012, Neurobiology of Aging.
[11] D. Mann,et al. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies , 2012, Neurobiology of Disease.
[12] William T. Hu,et al. Biomarkers in frontotemporal lobar degenerations—Progress and challenges , 2011, Progress in Neurobiology.
[13] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[14] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[15] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[16] Yu Wang,et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression , 2011, Annals of neurology.
[17] W. F. Abdo,et al. TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies , 2010, Acta Neuropathologica.
[18] T. Tokuda,et al. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease , 2010, Neurology.
[19] J. Trojanowski,et al. Novel CSF biomarkers for frontotemporal lobar degenerations , 2010, Alzheimer's & Dementia.
[20] M. Weiner,et al. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.
[21] J. Trojanowski,et al. Total and phosphorylated tau protein as biological markers of Alzheimer’s disease , 2010, Experimental Gerontology.
[22] John Q. Trojanowski,et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update , 2009, Acta Neuropathologica.
[23] E. Bigio,et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration , 2009, Acta Neuropathologica.
[24] H. Akiyama,et al. Identification of casein kinase-1 phosphorylation sites on TDP-43. , 2009, Biochemical and biophysical research communications.
[25] J. Trojanowski,et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies , 2009, Acta Neuropathologica.
[26] J. Trojanowski,et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2008, Archives of neurology.
[27] B. Mollenhauer,et al. Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration , 2008, Experimental Neurology.
[28] M. Morita,et al. Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2008, Annals of neurology.
[29] D. Neary,et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration , 2008, Acta Neuropathologica.
[30] J. Trojanowski,et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology , 2008, Neurology.
[31] J. Schneider,et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.
[32] David Mann,et al. Frontotemporal lobar degeneration: clinical and pathological relationships , 2007, Acta Neuropathologica.
[33] D. Dickson,et al. TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.
[34] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[35] P. Scheltens,et al. Cerebrospinal fluid tau levels in frontotemporal dementia , 2005, Annals of neurology.
[36] Jennifer Farmer,et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease , 2005, Annals of neurology.
[37] A Drzezga,et al. Tau and A&bgr;42 protein in CSF of patients with frontotemporal degeneration , 2002, Neurology.
[38] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[39] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[40] Frederik Barkhof,et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. , 2014, Journal of Alzheimer's disease : JAD.
[41] N. Kitchen,et al. Rostrocaudal Dynamics of CSF Biomarkers , 2010, Neurochemical Research.
[42] D. Mann,et al. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis , 2008, Acta Neuropathologica.
[43] M. O. Olde Rikkert,et al. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. , 2007, Clinical chemistry and laboratory medicine.